Company Profile:
Business Nature: Manufacturer
Company Overview:
Pars Darou is one of the leading pharmaceutical companies in Iran, established in 1961. It operates as a large-scale manufacturing enterprise specializing in the research, development, and production of a wide range of human pharmaceutical products. The company owns advanced production facilities and adheres to international Good Manufacturing Practice (GMP) standards. Its product portfolio covers various therapeutic categories, including cardiovascular, gastrointestinal, respiratory, and neurological medications, which are supplied primarily to the domestic Iranian market and exported to neighboring regions. As a manufacturer, the company focuses on high-quality drug formulation, quality control, and industrial-scale pharmaceutical synthesis.
Enterprise Products
Pars Darou Company Product Portfolio
Pharmaceutical Products:
1. Cardiovascular Agents:
Amlodipine Tablets
Atorvastatin Tablets
Bisoprolol Tablets
Losartan Potassium Tablets
Metoprolol Tablets
2. Gastrointestinal Agents:
Famotidine Tablets
Omeprazole Capsules
Pantoprazole Tablets
3. Central Nervous System Agents:
Alprazolam Tablets
Clonazepam Tablets
Diazepam Tablets
Fluoxetine Capsules
Sertraline Tablets
4. Analgesics and Anti-inflammatory Agents:
Celecoxib Capsules
Diclofenac Sodium Tablets
Ibuprofen Tablets
Meloxicam Tablets
5. Respiratory Agents:
Cetirizine Tablets
Loratadine Tablets
6. Antibiotics and Anti-infectives:
Amoxicillin Capsules
Ciprofloxacin Tablets
Metronidazole Tablets
7. Metabolic and Endocrine Agents:
Glibenclamide Tablets
Metformin Hydrochloride Tablets
8. Supplements and Vitamins:
Various Vitamin Supplements
Multivitamin Formulations
Note: The availability of these products may vary based on current production cycles and regulatory distribution within the Iranian market.